Market Overview

UPDATE: Nomura Reiterates Buy Rating, Lowers PT on on Health and Runway

Related AMZN
Why A Netflix Departure From This Consumer ETF Could Drive A Bearish Stance
Checking In On The Healthcare Sector Ahead Of Q1 Earnings Season
Amazon Stock: A Protracted Battle Looms Ahead (Seeking Alpha)

In a report published Wednesday, Nomura reiterated its Buy rating on (NASDAQ: AMZN), but lowered its price target from $325.00 to $300.00.

Nomura noted, “The AMZN sentiment pendulum has begun swinging toward ―negative as 4Q:12 revenue and unit deceleration has caused the stock to underperform the S&P 500 by ~690bp since 4Q results. In this note, we reinforce our view about why gross profit and gross merchandise value (GMV), not revenue, are more accurate metrics to assess AMZN‘s health and runway. There is no denying AMZN‘s revenue is slowing, but part of this deceleration is due to the growth of 3P business. Through this lens, AMZN‘s business appears more stable, growing ~37% in each of the past 3 years. Despite the cuts and a modestly lower non-CE estimate (to more closely track the recent pace of gains), the runway is still long, as our new GMV forecast only has AMZN reaching ~6% share of non-consumer electronics personal expenditure. We continue to rate AMZN Buy, as we are attracted to its GMV share-gaining story and path toward higher profitability. FY13E EPS from $1.68 to $1.73; FY14E EPS from $3.7 to $3.96.” closed on Tuesday at $269.75.

Latest Ratings for AMZN

Feb 2018MKM PartnersMaintainsBuyBuy
Feb 2018NomuraMaintainsBuyBuy
Feb 2018Credit SuisseMaintainsOutperformOutperform

View More Analyst Ratings for AMZN
View the Latest Analyst Ratings

Posted-In: NomuraAnalyst Color Price Target Analyst Ratings


Related Articles (AMZN)

View Comments and Join the Discussion!